NCT04049942

Brief Summary

In recent years, many studies have shown that prehabilitation based on aerobic training strategies could have a positive effect on the recovery of postoperative functional capacity in patients undergoing lung cancer surgery. Investigators are proposing a prospective randomized controlled trial to compare the impact of a short home-based multimodal prehabilitation strategy to preoperative aerobic training on patients scheduled for video-assisted thorascopic lobectomy for lung cancer. The multimodal prehabilitation strategy includes guided aerobic and resistance exercise, breathing exercises, nutrition supplement and physiology management preoperatively, while the aerobic strategy offers the same aerobic training guidance without the other parts. The prehabilitation lasts 2-3 weeks in our center. Investigators follow-up patients until 30 days after surgery, to investigate whether multimodal prehabilitation strategy differs from aerobic training program in postoperative functional capability improvement, health-related quality of life scorings, incidence of postoperative complications and other outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 8, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

December 28, 2022

Status Verified

August 1, 2022

Enrollment Period

4.3 years

First QC Date

July 30, 2019

Last Update Submit

December 26, 2022

Conditions

Keywords

PerioperativeFunctional capabilityPrehabilitationThoracoscopic lobectomyLung Cancer

Outcome Measures

Primary Outcomes (1)

  • post-operative 6-minute walk distance

    Use 6-minute walk distance (6MWD) to evaluate the physical functional capability objectively. The primary outcome will be analyzed after stratification by age and baseline functional capacity.

    30 days postoperatively

Secondary Outcomes (10)

  • Perioperative 6MWD

    baseline, 1 day before surgery

  • Perioperative pulmonary functional test

    Baseline, 1 day before surgery, 30 days postoperatively

  • Perioperative Hospital Anxiety and Depression Scale (HADS)

    Baseline, 1 day before surgery, 30 days postoperatively

  • WHO disability assessment schedule 2.0 (WHODAS 2.0)

    Baseline, 1 day before surgery, 30 days postoperatively

  • Postoperative quality of recovery score -15 (QoR-15)

    the 1st, 2nd and 3rd day postoperatively

  • +5 more secondary outcomes

Study Arms (2)

Prehabilitation group

EXPERIMENTAL

Multimodal prehabilitation strategy includes physical exercise (moderate aerobic exercise combined with resistance exercise and respiratory training ), nutritional suggestion and optimization(whey protein supplement), and psychological therapy, as well as conventional guidance (including preoperative anesthesia assessment, drug treatment recommendations for chronic disease, quit smoking and abstinence). Patients are advised to record daily exercises and adherence to nutritional, psychological and other recommendations. Short message interviews are sent to patients twice a week to optimize adherence and promote feedback.

Other: Multimodal prehabilitation group

Aerobic training group

EXPERIMENTAL

Aerobic training strategy includes the same guided individualized moderate aerobic exercise as the multimodal prehabilitation group, as well as the conventional guidance. Patients are advised to record daily exercises. Short message interviews are sent to patients twice a week to optimize adherence and promote feedback.

Behavioral: Aerobic training group

Interventions

Multimodal prehabilitation strategy includes physical exercise (moderate aerobic exercise combined with resistance exercise and respiratory training ), nutritional suggestion and optimization(whey protein supplement), and psychological therapy, as well as conventional guidance (including preoperative anesthesia assessment, drug treatment recommendations for chronic disease, quit smoking and abstinence). Patients are advised to record daily exercises and adherence to nutritional, psychological and other recommendations. Short message interviews are sent to patients twice a week to optimize adherence and promote feedback.

Prehabilitation group

Aerobic training strategy includes the same guided individualized moderate aerobic exercise as the multimodal prehabilitation group, as well as the conventional guidance. Patients are advised to record daily exercises. Short message interviews are sent to patients twice a week to optimize adherence and promote feedback.

Aerobic training group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatient of thoracic surgery department in Peking Union Medical College Hospital
  • From 18y/o to 70y/o
  • Suspected of lung cancer
  • Decide to take the elective thoracoscopic surgery in Peking Union Medical College Hospital

You may not qualify if:

  • Decline to participant the study (due to any reason)
  • American Society of Anesthesiologists (ASA) grade \>III
  • TNM stage I-III
  • Patients plan to receive neoadjuvant therapy
  • Unable to tolerate prehabilitaion or aerobic strategy (including exercise guide, whey protein and psycho-relaxation exercise)
  • Other severe cardio-pulmonary diseases that would affect the 6MWD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PekingUnionMedicalCollegeHospital

Beijing, Beijing Municipality, 100005, China

RECRUITING

Related Publications (1)

  • Liu Y, Liu Z, Zhang Y, Cui Y, Pei L, Huang Y. The protocol for the prehabilitation for thoracic surgery study: a randomized pragmatic trial comparing a short home-based multimodal program to aerobic training in patients undergoing video-assisted thoracoscopic surgery lobectomy. Trials. 2023 Mar 15;24(1):194. doi: 10.1186/s13063-023-07220-4.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Yuguang HUANG, M.D.

    Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

    STUDY CHAIR

Central Study Contacts

Yuguang HUANG, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2019

First Posted

August 8, 2019

Study Start

September 1, 2019

Primary Completion

December 30, 2023

Study Completion

March 30, 2024

Last Updated

December 28, 2022

Record last verified: 2022-08

Locations